Mr. Yang is the founding partner and CEO of Blue Ocean Capital Group ("BOCG”). He has over 20 years of experience in venture capital and private equity investment with US$ 1 billion proven track records. He led a symbolic US$ 250 million cross-border healthcare M&A which won him distinguished awards including “the Top 10 Private Equity Investments in China” and “the Best M&A Financing Award” of the year. Recent healthcare investments led by Mr. Yang including Hightide Therapeutics, Ribo Life Science, Boan Biotech, INNORNA and CureGenetics.

Before Mr. Yang founded BOCG, he served as the managing director of China Construction Bank International (“CCBI”), in charge of healthcare investment with dual currency funds. Mr. Yang is a PhD candidate of CUHK, holds the MBA degree from HKUST with exchange experience in Columbia University in New York and HHL Business School in Leipzig. He graduated from Zhongnan University of Economics and Law with a bachelor’s degree. 
‍